119 related articles for article (PubMed ID: 1084889)
1. Human serum binding capacity and affinity for 25-hydroxyergocalciferol and 25-hydroxycholecalciferol.
Haddad JG; Hillman L; Rojanasathit S
J Clin Endocrinol Metab; 1976 Jul; 43(1):86-91. PubMed ID: 1084889
[TBL] [Abstract][Full Text] [Related]
2. Acute administration of 25-hydroxycholecalciferol in man.
Haddad JG; Rojanasathit S
J Clin Endocrinol Metab; 1976 Feb; 42(2):284-90. PubMed ID: 177440
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: concentrations in normal subjects and patients with disorders of mineral homeostasis.
Haddad JG; Walgate J
J Clin Invest; 1976 Nov; 58(5):1217-22. PubMed ID: 1086857
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous measurement of serum 25-hydroxycholecalciferol and 25-hydroxyergocalciferol.
Delvin EE; Glorieux FH; Dussault M; Bourbonnais R; Watters G
Med Biol; 1979 Jun; 57(3):165-70. PubMed ID: 315501
[TBL] [Abstract][Full Text] [Related]
5. A competitive protein-binding assay for 25-hydroxycholecalciferol and 25-hydroxyergocalciferol in serum.
Preece MA; O'Riordan JL; Lawson DE; Kodicek E
Clin Chim Acta; 1974 Jul; 54(2):235-42. PubMed ID: 4546706
[No Abstract] [Full Text] [Related]
6. Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term.
Tsibris JC; Raynor LO; Buhi WC; Buggie J; Spellacy WN
J Clin Endocrinol Metab; 1980 Oct; 51(4):711-7. PubMed ID: 6998996
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of sera of various origin as sources of binding protein for the assay of 25-hydroxyvitamin D.
Loré F; Di Cairano G; Signorini AM
Boll Soc Ital Biol Sper; 1980 Nov; 56(21):2210-2. PubMed ID: 7213484
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
9. 25-Hydroxyvitamin D transport in human plasma. Isolation and partial characterization of calcifidiol-binding protein.
Haddad JG; Walgate J
J Biol Chem; 1976 Aug; 251(16):4803-9. PubMed ID: 821943
[TBL] [Abstract][Full Text] [Related]
10. Assessment of a two-step high-performance liquid chromatographic assay using dual-wavelength ultraviolet monitoring for 25-hydroxyergocalciferol and 25-hydroxycholecalciferol in human serum or plasma.
Norris RL; Thomas MJ; Craswell PW
J Chromatogr; 1986 Aug; 381(1):53-61. PubMed ID: 3490485
[TBL] [Abstract][Full Text] [Related]
11. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A
Popul Sci; 1982; (3):157-68. PubMed ID: 12266214
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral contraceptives on some biochemical aspects in bilharzial Egyptian females living in rural areas.
Hefnawi FI; Zein-el-abedin A; Saber MA; Abdel RS; Yousry F
Popul Sci; 1982; (3):63-72. PubMed ID: 12266218
[TBL] [Abstract][Full Text] [Related]
13. Some biochemical effects of long term oral contraceptive therapy on Egyptian females living in rural areas.
Hefnawi FI; Zein-el-abedin A; Saber MA; Abdel RS; Yousry F
Popul Sci; 1982; (3):101-12. PubMed ID: 12266211
[TBL] [Abstract][Full Text] [Related]
14. Anti-estrogens and plasma proteins. II. Contraceptive drugs and gestagens.
Barbosa J; Seal US; Doe RP
J Clin Endocrinol Metab; 1973 Apr; 36(4):706-14. PubMed ID: 4119677
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of orally administered [3H]ergocalciferol and [3H]cholecalciferol by dairy calves.
Sommerfeldt JL; Napoli JL; Littledike ET; Beitz DC; Horst RL
J Nutr; 1983 Dec; 113(12):2595-600. PubMed ID: 6317829
[TBL] [Abstract][Full Text] [Related]
16. The effect of altered prednisolone kinetics in patients with the nephrotic syndrome and in women taking oral contraceptive steroids on human mixed lymphocyte cultures.
Frey BM; Frey FJ
J Clin Endocrinol Metab; 1985 Feb; 60(2):361-9. PubMed ID: 3155524
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D metabolites in normal subjects during one year. A longitudinal study.
Tjellesen L; Christiansen C
Scand J Clin Lab Invest; 1983 Feb; 43(1):85-9. PubMed ID: 6604936
[TBL] [Abstract][Full Text] [Related]
18. Serum 25-hydroxycholecalciferol levels in women using oral contraceptives.
Schreurs WH; van Rijn HJ; van den Berg H
Contraception; 1981 Apr; 23(4):399-406. PubMed ID: 7273760
[TBL] [Abstract][Full Text] [Related]
19. [Studies on estradiol occupied and unoccupied receptors in human endometrial cytosol and nucleus: steroid receptors throughout the menstrual cycle and in cases of oral contraceptives administration (author's transl)].
Azumaguchi A; Tanaka S
Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):951-60. PubMed ID: 7304137
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
Lemay A; Dewailly SD; Grenier R; Huard J
J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
